Lumos Pharma Inc

NASDAQ:LUMO   10:31:38 AM EDT
16.18
+0.15 (+0.94%)
Other Pre-Announcement

Lumos Pharma Reports Initiation Of Phase 2B OraGrowtH210 Trial

Published: 11/10/2020 21:12 GMT
Lumos Pharma, Inc. (LUMO) - Lumos Pharma Announces the Initiation of Phase 2b Oragrowth210 Trial and Reports Third Quarter 2020 Financial Results.
Lumos Pharma Inc - Anticipates Data Read Out for Oragrowth210 Trial Mid-year 2022.
Lumos Pharma - Expects Cash on Hand Sufficient to Fund Current Operations Through Read-out of Phase 2b Oragrowth210 Trial, Completion of Oragrowth212 Trial.